These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 115076)
21. [Using the gel agglutination technique in the determination of erythrocytic antigens in blood donors]. Mazova AV; Gracheva LA Klin Lab Diagn; 2008 Jul; (7):37-9. PubMed ID: 18756733 [No Abstract] [Full Text] [Related]
23. Positive and negative effects of diagnostic intensities of ultrasound on erythrocyte blood group markers. Rosenfeld E; Romanowski U; Williams AR Ultrasonics; 1990 May; 28(3):155-8. PubMed ID: 2111055 [TBL] [Abstract][Full Text] [Related]
24. Composition of erythrocytic (ABO, Rh-Hr, Kell, MN) group antigens characteristic of the Ozurgeti district's population. Nagervadze M; Diasamidze A; Khukhunaishvili R; Akhvlediani L; Koridze M; Dumbadze G; Tskvitinidze S Georgian Med News; 2010 Nov; (188):51-5. PubMed ID: 21178204 [TBL] [Abstract][Full Text] [Related]
25. Incompatible blood transfusions in liver transplant patients with significant red cell alloantibodies. Ramsey G; Cornell FW; Hahn LF; Fonzi F; Starzl TE Transplant Proc; 1989 Jun; 21(3):3531. PubMed ID: 2500759 [No Abstract] [Full Text] [Related]
26. Rhesus and Kell Phenotyping of Voluntary Blood Donors: Foundation of a Donor Data Bank. Karim F; Moiz B; Muhammad FJ; Ausat F; Khurshid M J Coll Physicians Surg Pak; 2015 Oct; 25(10):757760-760. PubMed ID: 26454398 [TBL] [Abstract][Full Text] [Related]
27. Validation of a hospital-laboratory workstation for immunohematologic methods. Schoenfeld H; Pretzel KJ; von Heymann C; Neuner B; Kalus U; Kiesewetter H; Pruss A Transfusion; 2010 Jan; 50(1):26-31. PubMed ID: 19709392 [TBL] [Abstract][Full Text] [Related]
28. [Significance of erythrocytic Kell antigen for predicting the development of congenital fetal malformations]. Bykova EIa; Andreeva EI; Purinia GO; Khemiĭ LR Akush Ginekol (Mosk); 1990 Nov; (11):31-3. PubMed ID: 2127655 [No Abstract] [Full Text] [Related]
29. Human monoclonal antibodies against blood group antigens. Preparation of a series of stable EBV immortalized B clones producing high levels of antibody of different isotypes and specificities. Goossens D; Champomier F; Rouger P; Salmon C J Immunol Methods; 1987 Aug; 101(2):193-200. PubMed ID: 3039005 [TBL] [Abstract][Full Text] [Related]
30. Expression of blood group antigens on red cell microvesicles. Oreskovic RT; Dumaswala UJ; Greenwalt TJ Transfusion; 1992; 32(9):848-9. PubMed ID: 1281942 [TBL] [Abstract][Full Text] [Related]
31. [Automatic blood group determination in the ABO- and Rh-system using conductometry]. Schmidt FP; Bormann R; Reichelt H; Höhme F Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):399-404. PubMed ID: 1703109 [TBL] [Abstract][Full Text] [Related]
33. [Determination of Lewis and P blood group phenotypes with the aid of the Autogrouper 16C]. Girard M; Michaud C Rev Fr Transfus Immunohematol; 1980 May; 23(2):141-5. PubMed ID: 7455481 [TBL] [Abstract][Full Text] [Related]
34. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel? Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895 [No Abstract] [Full Text] [Related]
35. Genetic association in vitiligo: ABO, MNSs, Rhesus, Kell and Duffy blood groups. Wasfi AI; Saha N; El Munshid HA; El Sheikh FS; Ahmed MA Clin Genet; 1980 Jun; 17(6):415-7. PubMed ID: 6772363 [TBL] [Abstract][Full Text] [Related]
36. Use of stroma for the detection of blood-group antibodies by ELISA. Giannitsis DJ; Flierl D; Schuler G; Häcker-Shahin B Infusionstherapie; 1990 Aug; 17(4):217-9. PubMed ID: 2210864 [TBL] [Abstract][Full Text] [Related]
37. [Blood transfusion complications due to factor hr'(c) incompatibility in patients with rhesus-positive blood]. Skachilova NN; Umnova MA; Ichalovskaia TA; Beliaev VV; Oshkina NP Probl Gematol Pereliv Krovi; 1980 Feb; 25(2):35-41. PubMed ID: 6767234 [No Abstract] [Full Text] [Related]
38. Optimal blood grouping and antibody screening for safe transfusion. Makarovska-Bojadzieva T; Blagoevska M; Kolevski P; Kostovska S Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535 [TBL] [Abstract][Full Text] [Related]
39. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan. Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030 [TBL] [Abstract][Full Text] [Related]
40. Anti-Kell (K1) in idiopathic thrombocytopenic purpura. O'Brien M; King G; Dube VE; Siegel M; Earlywine J Transfusion; 1979; 19(5):558-61. PubMed ID: 388757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]